.navbar .collapse { display: block; } .mobile-nav { max-height: none !important; } @media screen and (min-width: 1200px) { .navbar #basic-navbar-nav .navbar-nav { position: static !important; } }

Spotlight

In-person and virtual events just for HCPs

SpecialtySee All >

Breast Cancer
Lung Cancer
Gastrointestinal Cancer
Genitourinary Cancers
Ovarian Cancer
Prostate Cancer
Melanoma & Skin Cancer
MCL
MPN
CAR T-cell Therapy
Chronic Lymphocytic Leukemia
Gynecologic Oncology
Hematologic Oncology
Immuno-Oncology
Multiple Myeloma
Urothelial Cancer

Advertise
About OncLive
Editorial Board
MJH Life Sciences brands
Contact Us
Privacy
Terms & Conditions
Do Not Sell My Information

2 Clarke Drive
Suite 100
Cranbury, NJ 08512

New Treatment Strategies for Follicular Lymphoma

EP. 1: Diagnosis and Staging for Follicular Lymphoma

January 23rd 2018

EP. 2: Risk Stratification and Outcomes in Follicular Lymphoma

January 23rd 2018

EP. 3: FL: Monitoring to Initiate Therapy and Gauge Response

January 23rd 2018

EP. 4: Frontline Treatment Approaches to Follicular Lymphoma

January 23rd 2018

EP. 5: Optimizing Frontline Therapy and Maintenance in FL

January 23rd 2018

EP. 6: Treatment Approaches to Relapsed Refractory FL

January 23rd 2018

EP. 7: Further Considerations for Relapsed/Refractory FL

January 23rd 2018

EP. 8: Immunomodulatory Therapy for FL: The R-Squared Regimen

January 23rd 2018

EP. 9: FL: Updated Data for Immunomodulatory Approaches

January 23rd 2018

EP. 10: Emerging Therapies for Follicular Lymphoma

January 23rd 2018